Fractionated Carbon Dioxide Laser Therapy for Treatment of Peyronie's Disease

NACompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Peyronies Disease
Interventions
DEVICE

Fractional Carbon Dioxide Laser Therapy at 10-15% Laser Density Coverage

Fractional Carbon Dioxide Laser Therapy is an ablative therapy where abnormal collagen in scarred tissue is destroyed to permit the formation of more organized collagen. Previous studies have demonstrated its efficacy in treating medical conditions (ex. hypertrophic scars) similar to Peyronies Disease. There is evidence that Fractional Carbon Dioxide Laser Therapy has the ability to target and alter the molecular pathways that are similar to the ones that lead to Peyronie's Disease.

Trial Locations (1)

V5Z1M9

Diamond Health Care Centre, Vancouver

All Listed Sponsors
lead

University of British Columbia

OTHER